These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7202474)

  • 1. Cerebrospinal fluid concentrations of thioridazine and its main metabolites in psychiatric patients.
    Nyberg G; Axelsson R; Mårtensson E
    Eur J Clin Pharmacol; 1981 Jan; 19(2):139-48. PubMed ID: 7202474
    [No Abstract]   [Full Text] [Related]  

  • 2. Binding of thioridazine and thioridazine metabolites to serum proteins in psychiatric patients.
    Nyberg G; Axelsson R; Mårtensson E
    Eur J Clin Pharmacol; 1978 Dec; 14(5):341-50. PubMed ID: 32045
    [No Abstract]   [Full Text] [Related]  

  • 3. Concentrations of thioridazine and thioridazine metabolites in erythrocytes.
    Svensson C; Nyberg G; Axelsson R; Mårtensson E
    Psychopharmacology (Berl); 1986; 89(3):291-2. PubMed ID: 3088651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of thioridazine in psychiatric patients and healthy volunteers.
    Mårtensson E; Roos BE
    Eur J Clin Pharmacol; 1973 Oct; 6(3):181-6. PubMed ID: 4762056
    [No Abstract]   [Full Text] [Related]  

  • 5. Total plasma concentrations, red blood cell concentrations, and radioreceptor assay values compared with unbound plasma concentrations of thioridazine and thioridazine metabolites in psychiatric patients.
    Nyberg G; Svensson C; Olofsson U; Axelsson R; Mårtensson E
    Ther Drug Monit; 1987 Dec; 9(4):426-32. PubMed ID: 3424408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pilot of plasma thioridazine and metabolites in chronically treated patients.
    Papadopoulos AS; Chand TG; Crammer JL; Lader S
    Br J Psychiatry; 1980 Jun; 136():591-6. PubMed ID: 7388266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum concentration and protein binding of thioridazine and its metabolites in patients with chronic alcoholism.
    Axelsson R; Mårtensson E; Alling C
    Eur J Clin Pharmacol; 1982 Oct; 23(4):359-63. PubMed ID: 7173306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The assay of plasma concentration of thioridazine and its metabolites as a function of time.
    Gottschalk LA; Dinovo EC; Nandi BR
    Commun Psychopharmacol; 1978; 2(6):475-9. PubMed ID: 747914
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasma concentrations of thioridazine metabolites and ECG abnormalities.
    Gottschalk LA; Dinovo E; Biener R; Nandi BR
    J Pharm Sci; 1978 Feb; 67(2):155-7. PubMed ID: 621628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered white cell count, protein concentration and oligoclonal IgG bands in the cerebrospinal fluid of many patients with acute psychiatric disorders.
    Ahokas A; Koskiniemi ML; Vaheri A; Rimón R
    Neuropsychobiology; 1985; 14(1):1-4. PubMed ID: 4069344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of thioridazine and its metabolites in blood plasma and the brain of rats after acute and chronic treatment.
    Daniel WA; Syrek M; Mach A; Wójcikowski J; Boksa J
    Pol J Pharmacol; 1997; 49(6):439-52. PubMed ID: 9566048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of thioridazine in blood and urine.
    Ng CH; Crammer JL
    Br J Clin Pharmacol; 1977 Apr; 4(2):173-83. PubMed ID: 16633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disparate serum thioridazine concentrations: liquid chromatography versus radioreceptor assay.
    Linnoila M; Rosenblatt JE; Jeste D; Skinner T; Potter WZ; Wyatt RJ
    Acta Pharmacol Toxicol (Copenh); 1982 Jan; 50(1):25-9. PubMed ID: 7064715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unbound plasma concentrations, total plasma concentrations, and red blood cell concentrations of thioridazine and its main metabolites: an in vitro study.
    Nyberg G; Mårtensson E
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Apr; 335(4):465-8. PubMed ID: 3600822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relevance of CYP2D6 -1584C>G polymorphism for thioridazine:mesoridazine plasma concentration ratio in psychiatric patients.
    Dorado P; Peñas-LLedó EM; de la Rubia A; LLerena A
    Pharmacogenomics; 2009 Jul; 10(7):1083-9. PubMed ID: 19604081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of thioridazine and some of its metabolites to human serum protein and human albumin.
    Belpaire FM; Vanderheeren FA; Bogaert MG
    Arzneimittelforschung; 1975; 25(12):1969-71. PubMed ID: 1243669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Red blood cell and plasma levels of thioridazine and mesoridazine in schizophrenic patients.
    Shvartsburd A; Nwokeafor V; Smith RC
    Psychopharmacology (Berl); 1984; 82(1-2):55-61. PubMed ID: 6420831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gas-liquid chromotographic determination of perazine, thioridazine and thioridazine metabolites in human plasma.
    Vanderheeren FA; Theunis DJ
    J Chromatogr; 1976 May; 120(1):123-8. PubMed ID: 5459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A fixed dose study of the plasma concentration and clinical effects of thioridazine and its major metabolites.
    Cohen BM; Lipinski JF; Waternaux C
    Psychopharmacology (Berl); 1989; 97(4):481-8. PubMed ID: 2498945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. QTc interval lengthening is related to CYP2D6 hydroxylation capacity and plasma concentration of thioridazine in patients.
    LLerena A; Berecz R; de la Rubia A; Dorado P
    J Psychopharmacol; 2002 Dec; 16(4):361-4. PubMed ID: 12503836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.